dLocal, a Uruguay-based cross-border payment platform, raised USD617.7m in its IPO in the NASDAQ at a reported USD6.1b valuation. Alkeon Capital led a USD150m round earlier this year with participation from…
-
-
Alkeon Capital led a USD150m round for dLocal, a Uruguay-based cross-border payment platform, with participation from BOND, D1 Capital Partners and Tiger Global, at a reported USD5b valuation. General Atlantic…
-
Linzor Capital Partners has acquired a majority stake in Sies Salud, a Colombia-based healthcare services company specializing in HIV treatments. (Press Release) Linzor Capital Partners acquired a majority stake in…
-
Patagonia Capital Partners, Inverlat, and Quadrant Invest in Uruguayan Engagement Platform S1Gateway
Buenos Aires- based private investment firm Patagonia Capital Partners and Inverlat, and NY-based Quadrant Management, made an undisclosed investment in S1Gateway, an Uruguayan omnichannel communication and engagement platform for direct…
-
Linzor Capital Partners has acquired a majority stake in Uno Salud Dental, a Chilean dental care and aesthetic company. The amount of the transaction was undisclosed. (Press Release) Linzor Capital…
-
Software Uruguay-based company Memory has announced a merger with Colombia-based Accel-KKR backed Siigo. (Press Release) Memory, empresa líder en Uruguay en software contable, de gestión de empresas y de facturación…
-
General Atlantic led a US$200m investment in dLocal, a Uruguay-based cross-border payment platform, with participation from Addition, a new NY-based fund led by Lee Fixel, former Head of Private Equity…
-
Uncork Capital and Bling Capital led a US$2.2m seed round in MonkeyLearn, a Uruguayan no-code data analytics platform. (TechCrunch) A few years back, startups focusing on artificial intelligence had a…
-
TheVentureCity led a US$3m Series A in SimpliRoute, a Chilean logistics intelligence platform, to strengthen its presence in Mexico, Colombia and Uruguay. ChileGlobal Ventures, Wayra Chile, and 500 Startups invested…
-
Uruguay-based biotech Eolo Pharma raised a US$2.7m Series A from CITES and a group of international investors to fund preclinical trials for an obesity treatment. Eolo Pharma is run by…
Newer Posts